Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 3
Submit an article Journal homepage
3,335
Views
6
CrossRef citations to date
0
Altmetric
Cardiovascular

Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting

Masatsugu HoriOsaka International Cancer Institute, Osaka, Japan; View further author information
,
Norio TanahashiDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University Saitama International Medical Center, Hidaka, Japan; View further author information
,
Sayako AkiyamaBayer Yakuhin Ltd, Tokyo, Japan; View further author information
,
Grace KiyabuCreativ Ceutical K.K., Tokyo, Japan; View further author information
,
Julie DoreyCreativ Ceutical, Paris, France; Correspondence[email protected]
View further author information
&
Rei GotoGraduate School of Business Administration, Keio University, Yokohama, JapanView further author information
Pages 252-261 | Received 28 Aug 2019, Accepted 31 Oct 2019, Published online: 23 Nov 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Manaye Tamrie Derseh, Kiflom Solomon, Wasihun Tamene, Wosenie Beneberu, Ashagrachew Tewabe Yayehrad & Abyou Seyfu Ambaye. (2021) A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia. ClinicoEconomics and Outcomes Research 13, pages 821-834.
Read now

Articles from other publishers (5)

Yan Li, Pingyu Chen, Xintian Wang, Qian Peng, Shixia Xu, Aixia Ma & Hongchao Li. (2023) Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review. Applied Health Economics and Health Policy.
Crossref
Hiroshi Kawakami, Makoto Saito, Tomoki Fujisawa, Takayuki Nagai, Kazuhisa Nishimura, Yusuke Akazawa, Toru Miyoshi, Akinori Higaki, Fumiyasu Seike, Haruhiko Higashi, Katsuji Inoue, Shuntaro Ikeda & Osamu Yamaguchi. (2023) A cost-effectiveness analysis of remote monitoring after pacemaker implantation for bradycardia in Japan. Journal of Cardiology.
Crossref
Rini Noviyani, Sitaporn Youngkong, Surakit Nathisuwan, Bhavani Shankara Bagepally, Usa Chaikledkaew, Nathorn Chaiyakunapruk, Gareth McKay, Piyamitr Sritara, John Attia & Ammarin Thakkinstian. (2022) Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. BMJ Evidence-Based Medicine 27:4, pages 215-223.
Crossref
Neda AlrawashdhAli McBrideMarion SlackDaniel PerskyLeslie AndritsosIvo Abraham. (2022) Cost-effectiveness and value of information analyses of Bruton’s tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States. Journal of Managed Care & Specialty Pharmacy 28:4, pages 390-400.
Crossref
Neda Jaberi, Zahra Kavosi, Etrat Hooshmandi, Nasrin Moradi, Khosro Keshavarz & Afshin Borhani-Haghighi. (2021) The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke. Stroke Research and Treatment 2021, pages 1-8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.